Etiological Surveillance of Vaginal Discharge Syndrome in South Africa: 2019 to 2020

Sex Transm Dis. 2022 Aug 1;49(8):565-570. doi: 10.1097/OLQ.0000000000001646. Epub 2022 May 13.

Abstract

Background: The syndromic management of vaginal discharge syndrome (VDS) is challenging because of the prevalence of mixed infection with sexually transmitted infection (STI) pathogens and non-STI causes, such as bacterial vaginosis and candidiasis (CA). We aimed to determine the relative prevalence of VDS etiologies in women presenting to sentinel primary health care clinics in South Africa. Secondary objectives were to ascertain the predictive value of speculum findings for the presence of STI pathogens and the proportion of women presenting with clinical features of CA who had identifiable yeast on vaginal smear microscopy.

Methods: Consecutive, consenting women with complaints of abnormal vaginal discharge were enrolled between January 1, 2019, and December 31, 2020. Genital discharge swab and blood specimens were collected and transported to a central STI reference laboratory in Johannesburg.

Results: A total of 364 women were enrolled at 3 sentinel sites. Bacterial vaginosis was the most common cause of VDS (163 of 361 [45.2%]; 95% confidence interval [CI], 40.1%-50.3%); however, a significant proportion had STI coinfection (71 of 163 [43.6%]; 95% CI, 35.8%-51.5%). The predominant STI etiology was Chlamydia trachomatis (73 [20.2%]; 95% CI, 16.4%-24.7%). An abnormal speculum finding had poor predictive value for STIs, and Gram stain microscopy showed yeast in only 37.2% of vaginal smears from women with CA symptoms.

Conclusions: Bacterial vaginosis is the predominant cause of VDS in South Africa; however, STI coinfection is common. Clinical findings are poorly predictive of STI etiologies or candidiasis; therefore, a rapid and accurate STI point-of-care test would be useful in optimizing VDS management.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Candidiasis* / complications
  • Coinfection* / epidemiology
  • Female
  • Humans
  • Prevalence
  • Saccharomyces cerevisiae
  • Sexually Transmitted Diseases* / complications
  • Sexually Transmitted Diseases* / diagnosis
  • Sexually Transmitted Diseases* / epidemiology
  • South Africa / epidemiology
  • Vaginal Discharge* / diagnosis
  • Vaginal Discharge* / epidemiology
  • Vaginal Discharge* / etiology
  • Vaginosis, Bacterial* / complications
  • Vaginosis, Bacterial* / diagnosis
  • Vaginosis, Bacterial* / epidemiology